CXCR4 and metabolic dysfunction-associated steatohepatitis: Here, CXCL12 and CXCR4 protein levels are significantly increased, and CD4+ T cells are hyperresponsive to CXCL12 in NASH liver (Bigorgne et al., 2008; Li et al., 2020).